Your First Steps After a 46,XY DSD Diagnosis
At a Glance
A 46,XY DSD diagnosis means internal or external sex characteristics developed differently than expected for a 46,XY karyotype. This is rarely a medical emergency. Take time to build a multidisciplinary care team, seek peer support, and avoid rushing into irreversible surgical decisions.
Receiving a diagnosis of a 46,XY Difference of Sex Development (DSD)—whether for your infant or for yourself as an adolescent or young adult—can feel overwhelming. You may be experiencing a range of emotions, from shock and confusion to deep concern about the future [1][2]. It is important to know that these feelings are a completely natural response [3].
Biologically, sex development is a complex process. While a 46,XY karyotype (the collection of a person’s chromosomes) typically leads to typical male development, many factors—including genes and hormones—can lead to different outcomes [4][5]. A 46,XY DSD diagnosis simply means that the internal or external sex characteristics differ from what is typically expected for these chromosomes [6].
Understanding the Terms
Terminology in this field is evolving to be more patient-centered and less stigmatizing [7]. You may hear several different terms:
- Differences of Sex Development (DSD): Currently the most common clinical term used to describe these variations [8][9].
- Disorders of Sex Development: The original medical term established by the 2006 Chicago Consensus. While still used in some medical literature, many families, patients, and clinicians now prefer “Differences” [6][10].
- Intersex: A term often used by advocacy groups and individuals to describe their lived experience and connect with supportive communities [11][12].
- Variations of Sex Characteristics (VSC): A newer, descriptive term gaining traction in international and legal contexts [7].
Three Stabilizing Facts
When you are in the first days or weeks of a diagnosis, it is easy to feel a sense of urgency. The following facts can help ground you:
- In most cases, this is not a medical emergency. Unless the medical team has identified a rare adrenal issue (like certain forms of congenital adrenal hyperplasia) that requires immediate medication, the anatomical variations themselves are not a medical emergency [13]. Most individuals with 46,XY DSD are medically stable and healthy [13].
- There is time to make decisions. There is rarely a medical reason to rush into permanent decisions regarding surgery or gender assignment [13]. Current guidelines emphasize deferring irreversible interventions until a full diagnosis is reached and the patient can participate in the conversation [13][14].
- This is no one’s fault. Differences in sex development occur during early embryonic growth due to genetic variations or hormonal influences [4][5]. Nothing done before or during pregnancy caused this to happen.
Common Variations and Incidence
46,XY DSD is a “catch-all” term for many different conditions. Some are more common than others, though all are considered rare:
| Condition | Estimated Prevalence | Key Feature |
|---|---|---|
| Complete Androgen Insensitivity Syndrome (CAIS) | 2 to 5 per 100,000 [15] | The body does not respond to male hormones (androgens), typically resulting in a female appearance [16]. |
| Swyer Syndrome (Complete Gonadal Dysgenesis) | ~1 in 80,000 to 100,000 | The gonads (which would typically become testes) do not develop properly, resulting in underdeveloped ‘streak gonads’ [17]. |
| 5-Alpha Reductase Deficiency | Rare (Global data varies) [18] | The body cannot convert testosterone to a more potent form, often resulting in atypical genitalia at birth [19][20]. |
Moving Forward
The gold standard for care is a multidisciplinary team [21][9]. This team should include specialists in endocrinology (hormone doctors), urology or surgery, genetics, and psychology [22][23].
Modern medicine relies heavily on Next-Generation Sequencing (NGS)—a type of advanced genetic testing—to identify the specific cause of the DSD [24][14]. Finding a team that values your input, connects you with patient-led peer support, and respects bodily autonomy is the most important first step in this journey [25][26].
In this guide
4 chapters
The "Why": Causes and Genetic Testing in 46,XY DSD
Learn the causes of 46,XY DSD and how genetic testing works. Understand subtypes like AIS, 5-alpha reductase deficiency, and how to read your lab report.
Navigating Treatment, Surgical Decisions, and Identity
Learn about treatment options for 46,XY DSD. Understand the shift toward delaying elective surgeries, managing cancer risks, and supporting gender identity.
Long-Term Outlook: Hormones, Cancer Risk, and Fertility
Learn about the long-term outlook for 46,XY DSD. Understand hormone replacement therapy, managing gonadal cancer risks, fertility options, and mental health.
Building Your Care Team
Learn how to build a specialized care team for 46,XY DSD. Discover which specialists to include, what records to bring, and key questions to ask your doctors.
Common questions in this guide
Is a 46,XY DSD diagnosis a medical emergency?
Do we need to make decisions about DSD surgery right away?
What causes a 46,XY difference of sex development?
What specialists should be on our DSD care team?
Why is my doctor ordering next-generation sequencing?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Does the specific diagnosis involve any adrenal issues that require immediate medication or monitoring?
- 2.What specific genetic or hormonal tests have been ordered, and when can we expect those results?
- 3.Can you connect us with a multidisciplinary DSD team that includes a psychologist or social worker?
- 4.Based on the current findings, what are the different possibilities for the diagnosis?
- 5.Is there any medical reason why we would need to make decisions about surgery right now?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (26)
- 1
Uncertainty and Posttraumatic Stress: Differences Between Mothers and Fathers of Infants with Disorders of Sex Development.
Delozier AM, Gamwell KL, Sharkey C, et al.
Archives of sexual behavior 2019; (48(5)):1617-1624 doi:10.1007/s10508-018-1357-6.
PMID: 31144217 - 2
Predictors of Psychosocial Distress in Parents of Young Children with Disorders of Sex Development.
Perez MN, Delozier AM, Aston CE, et al.
The Journal of urology 2019; (202(5)):1046-1051 doi:10.1097/JU.0000000000000424.
PMID: 31268850 - 3
Parent-Rated Severity of Illness and Anxiety among Caregivers of Children Born with a Disorder of Sex Development Including Ambiguous Genitalia.
Sharkey CM, Bakula DM, Wolfe-Christensen C, et al.
Hormone research in paediatrics 2018; (90(5)):308-313 doi:10.1159/000495422.
PMID: 30566934 - 4
Clinical Spectrum, Surgical Management, and Outcomes of NR5A1-Related 46,XY Differences of Sex Development: A Narrative Review.
Vicario S, Escolino M, Esposito G, et al.
Medicina (Kaunas, Lithuania) 2025; (61(11)) doi:10.3390/medicina61111965.
PMID: 41303802 - 5
Genetic Variants in SRD5A2 in a Spectrum of DSD Patients from Australian Clinics Highlight Importance of Genetic Testing alongside Typical First-Line Investigations.
Robevska G, Hanna C, van den Bergen J, et al.
Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation 2023; (17(1)):8-15 doi:10.1159/000527754.
PMID: 36724755 - 6
Contexts of care for people with differences of sex development: Diversity is still missing in the laboratory routine.
Kulle AE, Jürgensen M, Döhnert U, et al.
Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V 2023; (35(3)):181-187 doi:10.1515/medgen-2023-2037.
PMID: 38840817 - 7
Evolving language reflects evolving understanding: updated terms for anatomical description in i/VSC/DSD.
Whitehead J, Adams M, Davies A, et al.
Nature reviews. Urology 2025; (22(6)):332-333 doi:10.1038/s41585-025-01035-5.
PMID: 40229428 - 8
Molecular Aspects of Sex Development in Mammals: New Insight for Practice.
Audí L, Bertelloni S, Flück CE
International journal of molecular sciences 2020; (21(23)) doi:10.3390/ijms21239146.
PMID: 33266346 - 9
Differences of Sex Development: Current Issues and Controversies.
Johnson EK, Whitehead J, Cheng EY
The Urologic clinics of North America 2023; (50(3)):433-446 doi:10.1016/j.ucl.2023.04.010.
PMID: 37385705 - 10
Clinical tools in the diagnosis of disorders of sex development: a switch from the hormonal to the genetics laboratory?
Rey RA
Advances in laboratory medicine 2021; (2(4)):463-467 doi:10.1515/almed-2021-0072.
PMID: 37360891 - 11
DSD/intersex: historical context and current perspectives.
Lee PA, Mazur T, Houk CP
Journal of pediatric endocrinology & metabolism : JPEM 2023; (36(3)):234-241 doi:10.1515/jpem-2022-0582.
PMID: 36630604 - 12
Intersexuality/Differences of Sex Development through the Discourse of Intersex People, Their Relatives, and Health Experts: A Descriptive Qualitative Study.
Moreno-Begines MLN, Arroyo-Rodríguez A, Borrallo-Riego Á, Guerra-Martín MD
Healthcare (Basel, Switzerland) 2022; (10(4)) doi:10.3390/healthcare10040671.
PMID: 35455848 - 13
"Congruency the ART of Being Real" - 46XY DSD Due to 5 α Reductase Deficiency - Challenges in Decision Making.
Subbiah S, Priyanka R, Jayaraman S
Indian journal of endocrinology and metabolism 2021; (25(5)):392-394 doi:10.4103/ijem.ijem_179_21.
PMID: 35300438 - 14
Contribution of Clinical and Genetic Approaches for Diagnosing 209 Index Cases With 46,XY Differences of Sex Development.
Gomes NL, Batista RL, Nishi MY, et al.
The Journal of clinical endocrinology and metabolism 2022; (107(5)):e1797-e1806 doi:10.1210/clinem/dgac064.
PMID: 35134971 - 15
Androgen Insensitivity Syndrome: A rare genetic disorder.
Fulare S, Deshmukh S, Gupta J
International journal of surgery case reports 2020; (71()):371-373 doi:10.1016/j.ijscr.2020.01.032.
PMID: 32493623 - 16
Disorders of sex development: a study of 194 cases.
Walia R, Singla M, Vaiphei K, et al.
Endocrine connections 2018; (7(2)):364-371 doi:10.1530/EC-18-0022.
PMID: 29386228 - 17
Germ Cell Tumors in 46, XY Gonadal Dysgenesis.
Misgar RA, Islam Mir SU, Mir MH, et al.
Indian journal of endocrinology and metabolism 2024; (28(4)):424-428 doi:10.4103/ijem.ijem_373_22.
PMID: 39371651 - 18
Integrative and Analytical Review of the 5-Alpha-Reductase Type 2 Deficiency Worldwide.
Batista RL, Mendonca BB
The application of clinical genetics 2020; (13()):83-96 doi:10.2147/TACG.S198178.
PMID: 32346305 - 19
Exploring the efficacy of testosterone undecanoate in male children with 5α-reductase deficiency.
Liu Y, Fan L, Wang X, Gong C
Pediatric investigation 2021; (5(4)):249-254 doi:10.1002/ped4.12302.
PMID: 34938965 - 20
Molecular Characterization of Steroid 5 Alpha-Reductase 2 (SRD5A2) Gene Variant in Indian Patients with Disorder of Sexual Development.
Kumar A, Kumar A, Rai S, et al.
Archives of sexual behavior 2025; (54(7)):2755-2761 doi:10.1007/s10508-025-03197-0.
PMID: 40839185 - 21
Clinical practice guidelines for the management of differences of sex development in Japan.
Ishii T, Kashimada K, Kawai M, et al.
Endocrine journal 2026; (73(2)):291-340 doi:10.1507/endocrj.EJ25-0392.
PMID: 41338999 - 22
Society for Endocrinology UK Guidance on the initial evaluation of a suspected difference or disorder of sex development (Revised 2021).
Ahmed SF, Achermann J, Alderson J, et al.
Clinical endocrinology 2021; (95(6)):818-840 doi:10.1111/cen.14528.
PMID: 34031907 - 23
Psychological support for individuals with differences of sex development (DSD).
Bennecke E, Strandqvist A, De Vries A, et al.
Journal of psychosomatic research 2024; (179()):111636 doi:10.1016/j.jpsychores.2024.111636.
PMID: 38507969 - 24
Molecular Diagnosis of 46,XY Disorders of Sex Development: An Efficient Initial Molecular Analysis Using a Custom-Designed Targeted Gene Panel in a Single-Center Study.
Poyrazoglu S, Aghayev A, Toksoy G, et al.
Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation 2026; (20(1-6)):15-25 doi:10.1159/000550371.
PMID: 41493898 - 25
Disorders or Differences of Sex Development? Views of Affected Individuals on DSD Terminology.
Bennecke E, Köhler B, Röhle R, et al.
Journal of sex research 2021; (58(4)):522-531 doi:10.1080/00224499.2019.1703130.
PMID: 31985272 - 26
Condition openness is associated with better mental health in individuals with an intersex/differences of sex development condition: structural equation modeling of European multicenter data.
van de Grift TC,
Psychological medicine 2023; (53(6)):2229-2240 doi:10.1017/S0033291721004001.
PMID: 34663488
This page provides general educational information about the first steps after a 46,XY DSD diagnosis. It is not intended to replace professional medical advice from a specialized multidisciplinary care team.
Get notified when new evidence is published on 46,XY difference of sex development.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.